Dear Editor,

Unfortunately, based on our analysis, contrary to meta-analysis by Yin et al. \[[@B1]\], studies they included in their meta-analysis were not in Hardy--Weinberg equilibrium (HWE), and many included articles (seven articles) show deviation from HWE, even after adjustment. It seems that authors made some mistake in calculating HWE. In [Table 1](#T1){ref-type="table"} we showed *P*-values for HWE test and ineligible studies, based on 'HardyWeinberg' package in R programming language (<https://cran.rproject.org/web/packages/>HardyWeinberg/HardyWeinberg.pdf). Our results were double checked with STATA (genhwi form of genhw, <https://www.stata.com/users/mcleves/genhw/genhw.hlp>), and also manually. In manual method, *P*-value of HWE test was calculated based on four following steps. (i) We calculated allele frequencies in control group: K = \[(2 × KK) + KE\]/(2 × total), so E should be E = 1 − K. (ii) We calculated expected genotypes based on allele frequencies: KK = K^2^ × total, KE = (2 × K × E) × total, and EE = EE^2^ × total. (iii) We carried out chi-square test between observed and expected genotypes (χ^2^ = Σ(Ob **−** Ex)^2^/Ex). (iv) Finally, results were interpreted based on chi-square routine distribution table (steps (i--iii) are shown in [Table 2](#T2){ref-type="table"} and step (iv) in [Table 3](#T3){ref-type="table"}). Also regarding the study by Sarecka-Hujar et al. \[[@B2]\], the genotyping data were not correctly included in [Table 1](#T1){ref-type="table"} of their meta-analysis, GG(EE) and AA(KK) genotypes and allele frequencies were displaced in both case and control groups. Correct data are shown in [Table 1](#T1){ref-type="table"}. Also, they \[[@B2]\] indicate that 'the distribution of ICAM1 genotypes was not compatible with HWE' which clearly violates inclusion criteria (iv) in Yin et al. \[[@B1]\] meta-analysis.

###### Genotyping data and HWE results for studies in Yin et al. \[[@B1]\] meta-analysis

  Studies                      Case KK   KE        EE       Control KK   KE        EE       *P*-value   Adjusted *P*-value   Design
  ---------------------------- --------- --------- -------- ------------ --------- -------- ----------- -------------------- -------------
  Shang, Q. (2005)             48        50        24       29           33        35       0.002       0.005                Exclude
  **Li, Y.J. (2010)**          **47**    **39**    **7**    **52**       **36**    **13**   **0.103**   **0.180**            **Include**
  Lu, F.H. (2006)              61        69        30       45           65        59       0.003       0.008                Exclude
  **Zhang, S.R. (2006)**       **111**   **52**    **10**   **69**       **59**    **13**   **0.940**   **0.973**            **Include**
  Rao, D. (2005)               84        41        20       59           19        66       \<0.001     \<0.001              Exclude
  **Wei, Y.S. (2006**)         **124**   **84**    **17**   **101**      **103**   **26**   **0.973**   **0.973**            **Include**
  Zhou, Y.L. (2006)            38        45        20       102          62        33       \<0.001     \<0.001              Exclude
  **Wang, M. (2005**)          **96**    **61**    **8**    **91**       **90**    **18**   **0.524**   **0.734**            **Include**
  Jiang, H. (2002)             202       226       100      60           66        87       \<0.001     \<0.001              Exclude
  **Milutinović, A. (2006)**   **47**    **72**    **33**   **65**       **109**   **41**   **0.695**   **0.811**            **Include**
  Sarecka-Hujar, B. (2009)     61        118       12       73           122       8        \<0.001     \<0.001              Exclude
  **Mohamed, A. (2010)**       **20**    **37**    **43**   **2**        **11**    **37**   **0.332**   **0.516**            **Include**
  **Luo, J.Y. (2014**)         **339**   **278**   **57**   **461**      **273**   **45**   **0.587**   **0.747**            **Include**
  Yang, M. (2014)              305       251       48       266          160       42       0.015       0.029                Exclude

Finally included articles are shown in bold.

###### Results of steps (i--iii) of manual HWE test

  Studies                    Ob = Observed genotypes   Allele frequency   Ex = Expected genotypes   X^2^   *P*-value                                         
  -------------------------- ------------------------- ------------------ ------------------------- ------ ----------- ------ ------- ------- ------ ------- -------------
  Shang, Q. (2005)           29                        33                 35                        97     0.47        0.53   21.3    48.3    27.3   9.75    **0.002**
  Li, Y.J. (2010)            52                        36                 13                        101    0.69        0.31   48.5    43.0    9.5    2.66    **0.103**
  Lu, F.H. (2006)            45                        65                 59                        169    0.46        0.54   35.5    83.9    49.5   8.59    **0.003**
  Zhang, S.R. (2006)         69                        59                 13                        141    0.70        0.30   68.8    59.4    12.8   0.01    **0.940**
  Rao, D. (2005)             59                        19                 66                        144    0.48        0.52   32.6    71.8    39.6   77.90   **\<0.001**
  Wei, Y.S. (2006)           101                       103                26                        230    0.66        0.34   101.1   102.8   26.1   0.00    **0.973**
  Zhou, Y.L. (2006)          102                       62                 33                        197    0.68        0.32   89.8    86.4    20.8   15.73   **\<0.001**
  Wang, M. (2005)            91                        90                 18                        199    0.68        0.32   92.9    86.1    19.9   0.41    **0.524**
  Jiang, H. (2002)           60                        66                 87                        213    0.44        0.56   40.6    104.8   67.6   29.19   **\<0.001**
  Milutinović, A. (2006)     65                        109                41                        215    0.56        0.44   66.4    106.2   42.4   0.15    **0.695**
  Sarecka-Hujar, B. (2009)   73                        122                8                         203    0.66        0.34   88.5    91.1    23.5   23.37   **\<0.001**
  Mohamed, A. (2010)         2                         11                 37                        50     0.15        0.85   1.1     12.8    36.1   0.94    **0.332**
  Luo, J.Y. (2014)           461                       273                45                        779    0.77        0.23   458.3   278.4   42.3   0.30    **0.587**
  Yang, M. (2014)            266                       160                42                        468    0.74        0.26   255.8   180.4   31.8   5.98    **0.015**

###### Chi-square distribution table

  *P*-value   χ^2^ (df = 1)
  ----------- ---------------
  0.995       0.000
  0.975       0.000
  0.20        1.642
  0.10        2.706
  0.05        3.841
  0.025       5.024
  0.02        5.412
  0.01        6.635
  0.005       7.879
  0.002       9.550
  0.001       10.828

After deleting studies with deviation from HWE and meta-analysis of included articles, we found completely different results. Genotyping data related to seven finally included articles \[[@B2]\], involving 1582 coronary heart disease (CHD) cases and 1715 controls, are shown in [Table 1](#T1){ref-type="table"} (shown in bold and black color), and meta-analysis results based on five different genetics models are presented in [Table 4](#T4){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}. According to our observation, we did not find a significant result in different and overall ethnicity in any genetic model. Finally, in contrast with Yin et al. \[[@B1]\] study and based on meta-analysis of studies in HWE, it can be concluded that ICAM-1 gene polymorphism E469K may not be related to the risk of CHD. More studies could help us to get a definitive result.
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###### Meta-analysis of CHD risk associated with the K469E polymorphism based on different genetics models

  Classification   Allelic (K vs. E) OR \[95% CI\]   *Q test P-*value   K/E + K/K vs. E/E OR \[95% CI\]   *Q test P-*value   KK vs. K/E + E/E OR \[95% CI\]   *Q test P-*value   K/E vs. K/K + E/E OR \[95% CI\]   *Q test P-*value
  ---------------- --------------------------------- ------------------ --------------------------------- ------------------ -------------------------------- ------------------ --------------------------------- ------------------
  Chinese          1.23 \[0.84--1.78\]               0.01               1.32 \[0.79--2.22\]               0.03               1.25 \[0.79--1.98\]              0.01               0.89 \[0.63--1.26\]               0.01
  Caucasian        1.79 \[0.50--6.44\]               0.01               1.75 \[0.41--7.52\]               0.01               2.14 \[0.39--11.7\]              0.03               1.26 \[0.55--2.93\]               0.06
  Overall          1.33 \[0.95--1.85\]               0.01               1.44 \[0.89--2.33\]               0.01               1.32 \[0.89--1.96\]              0.01               0.95 \[0.71--1.27\]               0.01

  Classification   K/K vs. E/E OR \[95% CI\]   *Q test P-*value   K/K vs. K/E OR \[95% CI\]   *Q test P*-value   K/E vs. E/E OR \[95% CI\]   *Q test P*-value      
  ---------------- --------------------------- ------------------ --------------------------- ------------------ --------------------------- ------------------ -- --
  Chinese          1.47 \[0.75--2.88\]         0.01               1.20 \[0.78--1.83\]         0.01               1.06 \[0.78--1.43\]         0.40                  
  Caucasian        2.48 \[0.27--22.49\]        0.01               1.19 \[0.75--1.88\]         0.24               1.49 \[0.43--5.10\]         0.01                  
  Overall          1.57 \[0.88--2.80\]         0.01               1.22 \[0.86--1.74\]         0.03               1.11 \[0.86--1.42\]         0.01                  
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